HIMMLER GOTTFRIED has a total of 21 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PHILOGEN SRL, KENTA BIOTECH AG and ONCOMED PHARM INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Argentina | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Micro-structure and nano-technology | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Himmler Gottfried | 21 |
#2 | Schlederer Thomas | 4 |
#3 | Redl Gerda | 3 |
#4 | Mudde Geert | 2 |
#5 | Wozniak-Knopp Gordana | 2 |
#6 | Ruker Florian | 2 |
#7 | Barrientes Africa Garcia | 1 |
#8 | De Paz Carrera Jose Luis | 1 |
#9 | Penades Ullate Soledad | 1 |
#10 | Kircheis Ralf | 1 |
Publication | Filing date | Title |
---|---|---|
EP2854848A1 | Secretory immunoglobulin deficiency treatment and prophylaxis | |
WO2013150138A1 | Secretory immunoglobulin complex | |
US2012010388A1 | LeY SPECIFIC BIOTHERAPEUTIC | |
EP0833942A2 | Process for the transcriptionless amplification of nucleic acids |